• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On linezolid efficacy and tolerability.

作者信息

De Lorenzo S, Centis R, D'Ambrosio L, Sotgiu G, Migliori G B

出版信息

Eur Respir J. 2012 Mar;39(3):770-2. doi: 10.1183/09031936.00116011.

DOI:10.1183/09031936.00116011
PMID:22379150
Abstract
摘要

相似文献

1
On linezolid efficacy and tolerability.关于利奈唑胺的疗效和耐受性。
Eur Respir J. 2012 Mar;39(3):770-2. doi: 10.1183/09031936.00116011.
2
Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.美罗培南/克拉维酸联合利奈唑胺治疗广泛耐药结核病。
Pediatr Infect Dis J. 2011 Sep;30(9):812-3. doi: 10.1097/INF.0b013e3182154b05.
3
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.含利奈唑胺方案治疗南非儿童耐多药结核病。
Int J Tuberc Lung Dis. 2012 Dec;16(12):1588-93. doi: 10.5588/ijtld.12.0322. Epub 2012 Oct 2.
4
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.关于《每日300毫克利奈唑胺治疗难治性耐多药和广泛耐药结核病》的评论
J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.
5
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.每日300毫克利奈唑胺剂量用于治疗难治性耐多药和广泛耐药结核病——作者回应
J Antimicrob Chemother. 2009 Nov;64(5):1119-20. doi: 10.1093/jac/dkp344. Epub 2009 Sep 10.
6
Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.利奈唑胺治疗耐多药和广泛耐药结核，纽约市，2000-06。
J Antimicrob Chemother. 2010 Apr;65(4):775-83. doi: 10.1093/jac/dkq017. Epub 2010 Feb 11.
7
Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.每日半剂量利奈唑胺治疗难治性耐多药结核病。
Int J Antimicrob Agents. 2009 Jan;33(1):92-3. doi: 10.1016/j.ijantimicag.2008.06.014. Epub 2008 Sep 11.
8
Linezolid for extensively drug-resistant tuberculosis.利奈唑胺用于广泛耐药结核病
N Engl J Med. 2013 Jan 17;368(3):290. doi: 10.1056/NEJMc1214183.
9
Linezolid for extensively drug-resistant tuberculosis.
N Engl J Med. 2013 Jan 17;368(3):290-1. doi: 10.1056/NEJMc1214183.
10
Linezolid for extensively drug-resistant tuberculosis.利奈唑胺用于广泛耐药结核病
N Engl J Med. 2013 Jan 17;368(3):291. doi: 10.1056/NEJMc1214183.

引用本文的文献

1
Clinical effectiveness and reliability of linezolid in the treatment of pulmonary tuberculosis complicated with severe pneumonia: a meta-analysis.利奈唑胺治疗肺结核合并重症肺炎的临床疗效及可靠性：一项荟萃分析
Am J Transl Res. 2022 Nov 15;14(11):7622-7631. eCollection 2022.
2
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres.针对耐药结核病治疗的个体化方案：两个意大利参考中心的回顾性研究。
BMC Infect Dis. 2019 Jun 28;19(1):564. doi: 10.1186/s12879-019-4211-0.
3
Linezolid for drug-resistant pulmonary tuberculosis.
利奈唑胺用于耐药性肺结核
Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2.
4
Tuberculosis elimination: where are we now?结核病消除：我们现在在哪里？
Eur Respir Rev. 2018 Jun 13;27(148). doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30.
5
Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.地拉曼尼与贝达喹啉治疗儿童耐多药和广泛耐药结核病：一项系统评价
J Thorac Dis. 2017 Jul;9(7):2093-2101. doi: 10.21037/jtd.2017.06.16.
6
Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.德拉马尼与贝达喹啉联合用于治疗耐多药和广泛耐药结核病：一项系统评价
Int J Mol Sci. 2017 Feb 7;18(2):341. doi: 10.3390/ijms18020341.
7
Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.治疗耐多药结核病（MDR-TB）药物的分类：证据与展望
J Thorac Dis. 2016 Oct;8(10):2666-2671. doi: 10.21037/jtd.2016.10.14.
8
New anti-tuberculosis drugs and regimens: 2015 update.新型抗结核药物与治疗方案：2015年更新
ERJ Open Res. 2015 May 6;1(1). doi: 10.1183/23120541.00010-2015. eCollection 2015 May.
9
Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis.利奈唑胺治疗耐多药（MDR）和广泛耐药（XDR）结核病的疗效与安全性：一项系统评价和荟萃分析
Ann Clin Microbiol Antimicrob. 2016 Jun 22;15(1):41. doi: 10.1186/s12941-016-0156-y.
10
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.碳青霉烯类药物治疗多重耐药和广泛耐药结核病：一项系统评价。
Int J Mol Sci. 2016 Mar 12;17(3):373. doi: 10.3390/ijms17030373.